公司概覽
業務類別 Biotechnology
業務概覽 Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products andclinical candidates designed to target different cell types within the body.
公司地址 177 E Colorado Boulevard, Suite 700, Pasadena, CA, USA, 91105
電話號碼 +1 626 304-3400
傳真號碼 +1 626 304-3401
公司網頁 https://www.arrowheadpharma.com
員工數量 711
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Dr. Christopher Anzalone,PhD Chairman of the Board, Chief Executive Officer and President 美元 981.05K 27/01/2026
Mr. James Hamilton Chief of Discovery and Translational Medicine 美元 617.51K 29/01/2025
Mr. Daniel Apel Chief Financial Officer and Principal Accounting Officer 美元 232.21K 25/11/2025
Mr. Patrick C. O'Brien Chief Operating Officer, General Counsel and Corporate Secretary 美元 653.94K 29/01/2025
 
董事會成員
董事會 職務 更新日期
Dr. Michael S. Perry, PhD Independent Director 27/01/2026
Dr. Christopher Anzalone,PhD Chairman of the Board, Chief Executive Officer and President 27/01/2026
Dr. Mauro Ferrari, PhD Independent Director 27/01/2026
Dr. Adeoye Olukotun, M.D.,M.P.H. Independent Director 27/01/2026
Mr. William D. Waddill Lead Independent Director 27/01/2026
Dr. Hongbo Lu, PhD Independent Director 27/01/2026
Ms. Victoria Vakiener Independent Director 27/01/2026
Dr. Matthew Gregory Cohen Independent Director 16/06/2026
 
所屬ETF (更新日期: 14/11/2026 02:37)
代號 名稱 佔比% ▼ 持有日期
ONEOStt Strt® SPDR® Russell 1000 Momt FocETF0.0002%30/10/2026
GNMXCorgi Genomics & Precision Medicine ETF0.0002%30/10/2026
SCDSJPMorgan Fundamental Data Sci Sm Cor ETF0.0002%30/10/2026
FEMGFidelity Enhanced Mid Cap Growth ETF0.0001%30/10/2026
AVIEAvantis Inflation Focused Equity ETF0.0001%30/10/2026
DFALDimensional US Large Cp Cor Eq Mkt ETF0.0001%30/10/2026
FSEGFidelity Enhanced Small Cap Growth ETF0.0001%30/10/2026
AVTMAvantis Total Equity Markets ETF0.0001%30/10/2026
REMCColumbia Research Enhanced Mid Cap ETF0.00004%31/10/2026
RADDAB US Research Advanced ETF0.00002%30/10/2026
RECIColumbia Research Enhanced Cor PrmIncETF0.00001%31/10/2026
FELCFidelity Enhanced Large Cap Core ETF0.000002%30/10/2026
ADPVAdaptiv™ Select ETF<0.000001%15/09/2026
AIEQAI Powered Equity ETF<0.000001%28/12/2023
BFORBarron's 400 ETF<0.000001%18/09/2026
DFAUDimensional US Core Equity Market ETF<0.000001%08/10/2026
DFUSDimensional US Equity Market ETF<0.000001%08/10/2026
FCUSPinnacle Focused Opportunities ETF<0.000001%05/02/2026
IBRNiShares Neuroscience and Healthcare ETF<0.000001%18/09/2026
JSMDJanus Henderson Small/Md Cp Gr Alpha ETF<0.000001%01/10/2026
  1    2    3    4    5    6   7    8  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.